LNTH 87.5 (-0.93%)
US5165441032Medical Diagnostics & ResearchDiagnostics & Research

Lantheus Holdings (LNTH) Competitor Comparison

We are evaluating the key criteria listed to compare Lantheus Holdings (LNTH) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - LNTH ranking 56 / 58

These are the competitors of Lantheus Holdings in the industry Diagnostics & Research ranked by linearity 5 years
1. Co-Diagnostics CODX
42.73
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. Anixa Biosciences ANIX
31.91
4. DarioHealth DRIO
31.71
5. Syneos Health SYNH
24.79
6. Heska HSKA
15.42
7. CareDx CDNA
12.93
8. Qiagen QGEN
12.49
9. Pacific Biosciences of California PACB
11.42
10. DexCom DXCM
10.27
11. Inotiv NOTV
10.24
12. Olink Holding OLK
8.53
13. NeoGenomics NEO
7.56
14. Myriad Genetics MYGN
7.54
15. Fulgent Genetics FLGT
7.09
16. Exact Sciences EXAS
7.07
17. Icon ICLR
6.38
18. Trinity Biotech TRIB
6.26
19. Aspira Womens Health AWH
5.9
20. Charles River Laboratories CRL
5.67
21. PerkinElmer PKI
4.97
22. Illumina ILMN
4.87
23. IQVIA Holdings IQV
4.76
24. Personalis PSNL
4.58
25. Neogen NEOG
4.43
26. Sotera Health SHC
4.33
27. IDEXX Laboratories IDXX
4.27
28. Quest Diagnostics DGX
3.97
29. Guardant Health GH
3.75
30. Twist Bioscience TWST
3.7
31. Enzo Biochem ENZ
3.69
32. Sera Prognostics SERA
3.45
33. Laboratory Corp of America Holdings LH
3.33
34. Interpace Biosciences IDXG
3.12
35. Bioventus BVS
3.12
36. National Research NRC
3.11
37. Agilent Technologies A
3.01
38. Thermo Fisher Scientific TMO
3
39. Mettler-Toledo MTD
2.53
40. Danaher DHR
2.53
41. Psychemedics PMD
2.53
42. Precipio PRPO
2.41
43. Waters WAT
2.41
44. Neuronetics STIM
2.28
45. Global Cord Blood CO
2.23
46. Exagen XGN
2.06
47. MDxHealth MDXH
2.04
48. MaxCyte MXCT
2.04
49. Biodesix BDSX
1.92
50. Prenetics Global PRE
1.81
51. Organovo Holdings ONVO
1.6
52. bioAffinity Technologies BIAF
1.59
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.75
56. Lantheus Holdings LNTH
0.48
57. Medpace Holdings MEDP
0.46
58. RadNet RDNT
0.36

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.